drugset / Trial / NCT06921395

Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).

NCT06921395 ↗

Phase 4 Recruiting 248 enrolled LG Chem
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this randomized, open-label, active-controlled, parallel-group, multicenter, phase IV study is to assess the efficacy and safety of Fang Le Shu versus Guo Na Fen used for controlled ovarian stimulation in infertile women undergoing In Vitro Fertilization-Embryo Transfer.

Timeline

Start
2025-02-15
Primary completion
2025-09-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fang Le Shu Protein / enzyme biologic 150 iu —
Subject Fang Le Shu Protein / enzyme biologic 225 iu —
Subject Fang Le Shu Protein / enzyme biologic 300 iu —
Comparator Guo Na Fen Protein / enzyme biologic 450 iu —

Indications